Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Yin Qiao San is a Traditional Chinese Medicine (TCM) herbal formula derived from the classic Yin Qiao San prescription, which was originally documented in the Qing Dynasty medical text *Systematic Differentiation of Warm Diseases* (Wen Bing Tiao Bian). The formula is traditionally used to treat "wind-heat" syndromes, such as the common cold and influenza, characterized by fever, sore throat, and cough. The "modified" version typically involves the addition or adjustment of specific botanical ingredients to enhance its antiviral, anti-inflammatory, and immunomodulatory properties for specific conditions. In the context of COVID-19, it has been investigated for its potential to alleviate respiratory symptoms and prevent disease progression. The specific modification mentioned in clinical trials was developed by the Second Affiliated Hospital of Guangzhou University of Chinese Medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Yin Qiao San.